+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biguanides Market Outlook 2026-2034: by Molecule (Metformin, Phenformin, Buformin), Indication, Dosage Form, Formulation Type

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6241921
UP TO OFF until Jan 01st 2027
The Biguanides Market is estimated at US$18.3 billion in 2026 and is projected to grow at a CAGR of 1.9% to reach US$21.3 billion by 2034.

Market Overview

The Biguanides Market covers biguanide antidiabetic medicines, principally metformin formulations, across the defined pharmaceutical channels.

Formulation and product presentation influence purchasing within the intended clinical use; access, distribution and dependable quality shape commercial supply.

Market Segmentation

By Molecule

  • Metformin
  • Phenformin
  • Buformin

By Indication

  • Type-2 Diabetes Mellitus
  • Prediabetes
  • Polycystic Ovary Syndrome (PCOS)
  • Gestational Diabetes Mellitus (GDM)

By Dosage Form

  • Immediate-Release Tablets
  • Extended-Release Tablets
  • Oral Solution

By Formulation Type

  • Monotherapy
  • Fixed-Dose Combinations (FDCs)

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Biguanides Market Overview
2.1. Biguanides Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Biguanides Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Biguanides Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Biguanides Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Biguanides Market Analysis By Molecule, 2025-2034
5.2.1. Metformin
5.2.2. Phenformin
5.2.3. Buformin
5.3. Biguanides Market Analysis By Indication, 2025-2034
5.3.1. Type-2 Diabetes Mellitus
5.3.2. Prediabetes
5.3.3. Polycystic Ovary Syndrome (PCOS)
5.3.4. Gestational Diabetes Mellitus (GDM)
5.4. Biguanides Market Analysis By Dosage Form, 2025-2034
5.4.1. Immediate-Release Tablets
5.4.2. Extended-Release Tablets
5.4.3. Oral Solution
5.5. Biguanides Market Analysis By Formulation Type, 2025-2034
5.5.1. Monotherapy
5.5.2. Fixed-Dose Combinations (FDCs)
6. North America Biguanides Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Biguanides Market Analysis By Molecule
6.3. North America Biguanides Market Analysis By Indication
6.4. North America Biguanides Market Analysis By Dosage Form
6.5. North America Biguanides Market Analysis By Formulation Type
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Biguanides Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Biguanides Market Analysis By Molecule
7.3. Europe Biguanides Market Analysis By Indication
7.4. Europe Biguanides Market Analysis By Dosage Form
7.5. Europe Biguanides Market Analysis By Formulation Type
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Biguanides Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Biguanides Market Analysis By Molecule
8.3. Asia-Pacific Biguanides Market Analysis By Indication
8.4. Asia-Pacific Biguanides Market Analysis By Dosage Form
8.5. Asia-Pacific Biguanides Market Analysis By Formulation Type
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Biguanides Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Biguanides Market Analysis By Molecule
9.3. Middle East and Africa Biguanides Market Analysis By Indication
9.4. Middle East and Africa Biguanides Market Analysis By Dosage Form
9.5. Middle East and Africa Biguanides Market Analysis By Formulation Type
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Biguanides Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Biguanides Market Analysis By Molecule
10.3. South and Central America Biguanides Market Analysis By Indication
10.4. South and Central America Biguanides Market Analysis By Dosage Form
10.5. South and Central America Biguanides Market Analysis By Formulation Type
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Biguanides Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Competitive Benchmarking and Market Structure
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Table Information